New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

A growing number of Americans are trying popular weight-loss drugs touted by celebrities, health care providers and others. Should you?

Weight-loss supplements recommended by influencers on social mead are generally ineffective for weight loss, but do have some benefits.

Famed late columnist preached the gospel of vitamin C, had definite take on what justice system should do with ‘evil’ ...

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...

Unlocking the mystery behind 24ot1jxa ingredient secrets is what everyone been talking about lately — and for good reason!

By shutting this “off switch,” immune cells called macrophages regain their ability to soak up cholesterol, potentially ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary swelling disorder, sending its shares up 33.3% in premarket trading.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...